ROLE OF CHEMOKINES IN MUCOSAL IMMUNITY: ORAL, RESPIRATORY & UROGENITAL PATHOGENS
ROLE OF CHEMOKINES IN MUCOSAL IMMUNITY: ORAL, RESPIRATORY & UROGENITAL PATHOGENS
批准号:
7335986
负责人:
James W Lillard
金额:
$15.78万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-06-01 至 2007-05-31
中文摘要
该子项目是利用NIH/NCRR资助的中心赠款提供的资源的许多研究子项目之一。子项目和研究者(PI)可能从另一个NIH来源获得主要资金,因此可以在其他CRISP条目中表示。所列机构为中心,不一定是研究者所在机构。本项目的第一个目的是评估粘膜和全身免疫缺陷的小鼠在产生或识别趋化因子后,粘膜免疫与Th 1或Th 2诱导方案。第二个目标是确定这些趋化因子用于增强获得性免疫的G蛋白依赖性和非依赖性机制。第三个目标将评估CD 28-B7和CD 40-CD 40 L相互作用以及B和T细胞分化对趋化因子介导的适应性免疫中发生的抗体、T辅助细胞因子和细胞毒性T细胞应答的作用。第四个目标将定义当趋化因子与蛋白抗原通过粘膜或全身途径给药时产生的Th 1和Th 2型细胞因子依赖性和非依赖性途径。拟议的研究将提供重要的和新的信息有关的细胞机制,趋化因子,RANTES,Lptn,IP-10和IL-8用于诱导和调节全身和粘膜免疫。
英文摘要
This subproject is one of many research subprojects utilizing the resources provided by a Center grant funded by NIH/NCRR. The subproject and investigator (PI) may have received primary funding from another NIH source, and thus could be represented in other CRISP entries. The institution listed is for the Center, which is not necessarily the institution for the investigator. The first aim of this project will assess the mucosal and systemic immunity in mice defective in the production or recognition of chemokines following mucosal immunization with Th1- or Th2-inducing regimens. The second aim will determine the G protein(s) - dependent and -independent mechanisms that these chemokines use to enhance acquired immunity. The third aim will assess the role of CD28-B7 and CD40-CD40L interactions as well as B and T cell differentiation for antibody, T helper cytokine, and cytotoxic T cell responses that occur in chemokine-mediated adaptive immunity. The fourth aim will define the Th1- and Th2-type cytokine -dependent and -independent pathways that result when chemokines are administered with protein antigen through mucosal or systemic routes. The proposed studies will provide important and novel information regarding the cellular mechanisms that chemokines, RANTES, Lptn, IP-10, and IL-8 use to induce and regulate systemic and mucosal immunity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Detection of HIV proteins in urine to diagnose infection
-
批准号:9908301
-
项目类别:
-
资助金额:$29.62万
-
财政年份:2019
-
负责人:James W Lillard
-
依托单位:
Novel pharmacogenomic approach for identifying T cell epitopes in replacement FVI
-
批准号:8646315
-
项目类别:
-
资助金额:$20.38万
-
财政年份:2014
-
负责人:James W Lillard
-
依托单位:
Treatment of Colitis using a Novel CXCR3 Biologic Antagonist
-
批准号:8734398
-
项目类别:
-
资助金额:$9.72万
-
财政年份:2013
-
负责人:James W Lillard
-
依托单位:
Evaluation of the Antigenicity of Black Restricted FVIII Haplotypes and Haplotype
-
批准号:8591385
-
项目类别:
-
资助金额:$18.45万
-
财政年份:2013
-
负责人:James W Lillard
-
依托单位:
Treatment of Colitis using a Novel CXCR3 Biologic Antagonist
-
批准号:8591890
-
项目类别:
-
资助金额:$19.72万
-
财政年份:2013
-
负责人:James W Lillard
-
依托单位:
CELLS AND TISSUES
-
批准号:8357152
-
项目类别:
-
资助金额:$26.11万
-
财政年份:2011
-
负责人:James W Lillard
-
依托单位:
CELLS AND TISSUES
-
批准号:8166164
-
项目类别:
-
资助金额:$24.17万
-
财政年份:2010
-
负责人:James W Lillard
-
依托单位:
ROLE OF CHEMOKINES IN MUCOSAL IMMUNITY: ORAL, RESPIRATORY & UROGENITAL PATHOGENS
-
批准号:7164251
-
项目类别:
-
资助金额:$11.96万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership
-
批准号:8727715
-
项目类别:
-
资助金额:$5.62万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Bioethics Shared Resource
-
批准号:10007644
-
项目类别:
-
资助金额:$0.77万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership
-
批准号:9211890
-
项目类别:
-
资助金额:$100.95万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership
-
批准号:8549117
-
项目类别:
-
资助金额:$66.03万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership
-
批准号:8889318
-
项目类别:
-
资助金额:$5.45万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
-
批准号:9358677
-
项目类别:
-
资助金额:$40.77万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Morehouse School of Med/Tuskegee U/UAB Comp. Cancer Center Partnership
-
批准号:8337812
-
项目类别:
-
资助金额:$106.83万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Morehouse School of Medicine/Tuskegee University/UAB Comprehensive Cancer Center Partnership
-
批准号:10007607
-
项目类别:
-
资助金额:$110.19万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
-
批准号:9211116
-
项目类别:
-
资助金额:$133.77万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
2/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
-
批准号:9212214
-
项目类别:
-
资助金额:$127.42万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
Admin supplement
-
批准号:9354643
-
项目类别:
-
资助金额:$16.71万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
3/3 Morehouse Sch of Medicine/Tuskegee Univ/University of Alabama Ca Ctr Partnership
-
批准号:9353540
-
项目类别:
-
资助金额:$16.23万
-
财政年份:2005
-
负责人:James W Lillard
-
依托单位:
国内基金
海外基金
登录
查看更多内容
KCTD10对2型免疫反应(Th2)的调控研究
-
批准号:2020JJ4441
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:任凯群
-
依托单位:
IL-6受体泛素化调控机制
-
批准号:32070775
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2020
-
负责人:李姝
-
依托单位:
乙烯合酶ACS家族的AEF蛋白调节拟南芥开花时间的机制研究
-
批准号:31970735
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:江静
-
依托单位:
USP13调控IL-18诱导的NF-κB活化的分子机制研究
-
批准号:31900556
-
项目类别:青年科学基金项目
-
资助金额:26.0万元
-
批准年份:2019
-
负责人:林恒
-
依托单位:
let-7通过SOCS1调控巨噬细胞极化及其在前列腺癌进展中的作用
-
批准号:81560465
-
项目类别:地区科学基金项目
-
资助金额:38.0万元
-
批准年份:2015
-
负责人:王志刚
-
依托单位:
纳米微粒载NF-κB圈套基因对神经发育缺陷大鼠模型的干预研究
-
批准号:30870892
-
项目类别:面上项目
-
资助金额:8.0万元
-
批准年份:2008
-
负责人:吕路线
-
依托单位: